Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction
Background In patients with cardiogenic shock (CS), acute myocardial infarction (AMI) is the most common cause, and a percutaneous microaxial ventricular assist device (Impella, Abiomed, Danvers, MA) is a choice for temporary mechanical circulatory support. However, data are limited on complications...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2023-09-01
|
| Серія: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Предмети: | |
| Онлайн доступ: | https://www.ahajournals.org/doi/10.1161/JAHA.123.030819 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|